Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma

British Journal of Plastic Surgery

Volumn 50, Issue 7, 1997, Pages 478-482

  Grover, R ^a   Ross, D A ^a   Wilson, G D ^a   Sanders, R ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MELANOMA; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0030730276     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0007-1226(97)91295-9     Document Type: Article

References (21)

1. Fidler IJ. The biology of melanoma metastasis. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneuns Melanoma (2nd ed.) Philadelphia: JB Lippincott Co., 1992: 112-29.
2. Balch CM, Soong SJ, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8,500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous Melanoma (2nd ed.) Philadelphia: JB Lippincott Co., 1992: 165-87.
3. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma III. Prognostic factors in melanoma patients with lymph node metastases. Ann Surg 1981; 193: 377-88.
4. Bishop JM. Molecular themes in oncogenesis. Cell 1991; 64: 235-48.
5. Evan GI, Littlewood TD. The role of c-myc in cell growth. Curr Opin Gen Dev 1993; 3: 44-9.
6. Riou GF. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix. Cancer Surv 1988; 7: 442-55.
7. Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI, Moore JP. Elevated expression of c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 1989; 4: 1463-8.
8. Morton DL, Foshag LJ, Hoon DSB. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surgery 1992; 216: 463-82.
9. Hedley DW, Freidlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333-5.
10. Grover R, Ross DA, Richman PI, Robinson B, Wilson GD. C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity. Eur J Surg Oncol 1996; 22: 342-6.
11. Kaplan EL, Meier P. Nonparametric estimation of incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
12. Peto R, Pike MC, Armitage P. Design and analysis of clinical trials requiring prolonged observation of each patient: analysis and examples. Br J Cancer 1977; 35: 457-81.
13. Cox DR. Regression model and life tables. Journal of the Royal Statistical Society 1972; 34: 187-220.
14. Cascinelli N, Bufalino R, Morabito A, Mackie R. Results of adjuvant Interferon study of WHO melanoma programme. Lancet 1994; 343.8902: 913.
15. Durkin K, Haagensen CD. An improved technique for the study of lymph nodes in surgical specimens. Ann Surg 1980; 191: 419-25.
16. Alitalo K, Schwab M. Oncogenic amplification in tumour cells. Adv Cancer Res 1986; 47: 235-81.
17. Littlewood TD, Evan GI. The role of myc oncogenes in growth and differentiation. Adv Dental Res 1990; 4: 69-79.
18. Heikkila R, Scwab G, Wickstrom E, Loke SL. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature 1987; 328: 445-9.
19. Versteeg R, Noordermeer IA, Kruse-Walters M. C-myc down regulates class I HLA expression in human melanomas. EMBO J 1988; 7: 1023-9.
20. Gaugler B, Van den Eynde B, Van der Bruggen P, Romero P, Gaforio JJ, Plaen ED et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994; 179: 921-30.
21. Lazaris AC, Theodoropoulos GE, Aroni K, Saetta, Davaris PS. Immunohistochemical expression of c-myc oncogene, heat shock protein 70 and HLA DR molecules in malignant cutaneous melanoma. Virchows Arch 1995; 426: 461-7.